Ceresity is a technology provider focused on the life sciences industry, offering an AI-powered suite of solutions designed to transform clinical trial design, execution, and monitoring. Their platform aims to reduce protocol amendments, optimize patient visit schedules, and ensure global regulatory compliance through intelligent, context-aware insights. The company's core offerings include 'Trial Axis' for protocol optimization and risk detection, and 'Data Synapse' for creating structured, interoperable data assets throughout the clinical trial lifecycle. By integrating AI into clinical operations, Ceresity aims to help pharma, biotech, and CROs accelerate clinical development and improve trial quality.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Clinical Trial Technology / AI
SIZE & FINANCIALS
Employees:1-50
Founded:2026
Ownership:private
Status:operating
FUNDING
Stage:Seed
0
COMPETITION
Position:Emerging
Competitors:Medidata Solutions, Veeva Systems, IQVIA, Saama Technologies
LEADERSHIP
Key Executives:
Akshay Daftary - Co-Founder & Director
Karan Daftary - Co-Founder
Gaurav Vyas - Head of Artificial Intelligence and Technical Innovation
LINKS
Website:ceresity.com
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Ceresity and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Ceresity. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.